2 minute read - 4th November 2022
Siemens to upgrade Llanberis facility and create new jobs
Siemens Healthineers is to make a multi-million pound investment to launch a healthcare centre of excellence in Llanberis, a move that will secure existing jobs and create new ones.
Siemens Healthineers is to consolidate its global operations for the manufacture of IMMULITE® blood analysis technology, used worldwide to aid the diagnosis of medical conditions, at its site in Llanberis, Gwynedd. This investment, with support from the Welsh government, will transform the site into an R&D facility for laboratory diagnostics enabling the development of enhanced diagnostic precision products for use in optimising patient care.
This significant investment by the Welsh government and Siemens Healthineers Llanberis will secure hundreds of high-quality jobs, including the creation of close to 100 new ones, with an average salary significantly above the local area average. More importantly, the project will ensure that the site has a future beyond 2030. The majority of employees live within 10 miles of the Llanberis site.
Current employees include former apprentices who were offered full-time jobs, and various employees who are currently enrolled in university. The new R&D facility will also see partnerships solidified with higher education institutions in Wales, namely Bangor University, Swansea University and Cardiff University. Siemens Healthineers has had a presence in Llanberis since 1992 and owns the 36-acre site.
Economy minister, Vaughan Gething, said: “I’m delighted to announce this significant investment, with Siemens Healthineers, in a new centre of excellence in research and development in Llanberis. Thanks to Welsh government support, we have secured and created hundreds of high-quality jobs for Gwynedd.
“Siemens Healthineers Llanberis is a strategically important employer for the whole of the north and this investment is a huge vote of confidence in the Welsh economy. The economic contract we have signed with Siemens Healthineers secures the current facility’s future, establishes an innovative research and development facility, promises fair work and a healthy and inclusive working environment for decades to come.”
Professor Fraser Logue, vice president and managing director of Siemens Healthineers Llanberis, added: “Laboratories and clinics in over 50 countries around the globe are reliant on the IMMULITE® reagents we manufacture at Llanberis, covering over 100 disease states and 570 allergy tests. The investment from the Welsh government is testament to the critical work our existing workforce of over 400 colleagues does and will enable us to move forward with our planned investment in the site.
“Close to 100 highly skilled jobs will be created as we seek to realise our shared ambition of transforming Siemens Healthineers Llanberis into a worldwide centre of excellence for laboratory diagnostics manufacturing and research and development.”